Axonics.com

Axonics.com has Server used 192.254.208.68 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2012-09-28 (9 years, 30 days) and hosted in Houston United States, server ping response time 61 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Axonics keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Axonics
2 Axonics modulation technologies
3 Axonics modulation
4 Axonics men
5 Axonics 10k
6 Axonics ceo
7 Axonics cfo
8 Axonics ifu
9 Axonics ipg

Hosting Provider

Website: Axonics.com
Hostname: 192-254-208-68.unifiedlayer.com
Country:
Region: TX
City: Houston
Postal Code: 77092
Latitude: 29.830099105835
Longitude: -95.473899841309
Area Code: 713
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (19 hours ago)

   » Bobbyjonesband.com (1 day ago)

   » Huishoubao.com (8 hours ago)

   » M1file.com (1 day ago)

   » Renhomesantalya.com (4 day ago)

   » Napadrivertours.com (1 day ago)

   » Barefootconsultants.com (1 hours ago)

Results For Websites Listing

Found 19 Websites with content related to this domain, It is result after search with search engine

Axonics® Sacral Neuromodulation Therapy For Patients

Axonics.com   DA: 15 PA: 15 MOZ Rank: 30

  • Pezzella A, McCrery R, Lane F, et al
  • Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system

Axonics Sacral Neuromodulation (SNM) System For Urinary

Fda.gov   DA: 11 PA: 50 MOZ Rank: 62

  • The Axonics Sacral Neuromodulation (SNM) System is a sacral nerve stimulation (SNS) system that is intended to treat urinary retention and the symptoms of overactive bladder

Axonics Implants For Urinary Or Bowel Incontinence

Myconfidentlife.com   DA: 19 PA: 26 MOZ Rank: 47

  • Axonics therapy works by stimulating the sacral nerves with tiny electrical pulses
  • The brain and the sacral nerves don’t communicate properly in individuals experiencing urinary or fecal incontinence
  • Axonics therapy works to better regulate the sacral nerves’ function
  • These nerves can then interpret signals from the brain and pass them

Axonics’ Sales Skyrocket 4,509% In 2 Years Orange County

Ocbj.com   DA: 12 PA: 50 MOZ Rank: 65

  • Axonics’ Sales Skyrocket 4,509% in 2 Years CEO SAYS URINARY IMPLANT WELL RECEIVED

Axonics® Ranked The Fastest Growing Publicly Traded

Medicaldevicesworld.com   DA: 27 PA: 50 MOZ Rank: 81

  • Axonics reported $150.3 million of revenue in the trailing twelve months ended June 30, 2021, compared to $3.3 million in the comparable period two years ago, representing a growth rate of just over 4,500%
  • “Since its founding, Axonics has focused on innovation and developing best-in-class incontinence solutions for patients.

Is Axonics Inc. (AXNX) A Good Stock To Buy

Insidermonkey.com   DA: 21 PA: 50 MOZ Rank: 76

  • (NASDAQ: AXNX) was in 22 hedge funds’ portfolios at the end of the second quarter of 2021

Analysts Estimate Axonics Modulation Technologies (AXNX

Zacks.com   DA: 13 PA: 50 MOZ Rank: 69

  • Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report
  • Get prepared with the key expectations.

AXNX Stock Price Axonics Inc. Stock Quote (U.S.: Nasdaq

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 47

  • is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to …

Axonics Sacral Neuromodulation (SNM) System

Fda.gov   DA: 11 PA: 50 MOZ Rank: 69

The Axonics Sacral Neuromodulation (SNM) System is a sacral nerve stimulation (SNS) system that is intended to treat bowel (fecal) incontinence using mild electrical pulses.

Axonics® Ranked The Fastest Growing Publicly Traded

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 81

  • (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has been named by the Orange County Business Journal as the fastest growing publicly traded company in Orange County.
  • Companies were ranked based on the growth in their revenue over a two-year period.

Axonics (AXNX) Scheduled To Post Earnings On Thursday

Marketbeat.com   DA: 18 PA: 50 MOZ Rank: 78

  • Axonics, Inc is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction
  • Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women.

Medtronic Is Winning Its Patent Battle With Axonics, So

Mddionline.com   DA: 18 PA: 50 MOZ Rank: 79

  • The PTAB agreed with Axonics on four of the five claims Axonics is contesting in the ‘069 Patent, holding that those four claims are invalid and unpatentable
  • In addition, the PTAB upheld the nearly expired claims in the ‘756 Patent and the ‘314 Patent
  • The ‘756 Patent expires on November 9, 2021, and the ‘314 Patent expires on

Axonics, Inc. Hiring Customer Service Specialist In Irvine

Linkedin.com   DA: 16 PA: 50 MOZ Rank: 78

  • Be among the first 25 applicants
  • Job Scope: To enhance the customer experience of external and

Axonics, Inc. (AXNX) Stock Price, News, Quote & History

Finance.yahoo.com   DA: 17 PA: 12 MOZ Rank: 42

  • Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County
  • IRVINE, Calif., October 26, 2021--Axonics, Inc
  • (Nasdaq: AXNX), a global medical technology company that is

Axonics Company Profile

Craft.co   DA: 8 PA: 8 MOZ Rank: 30

Axonics Modulation Technologies is a medical device company developing a neuromodulation platform based on miniaturized rechargeable technology directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.

Axonics: Buy At The High

Fool.com   DA: 12 PA: 46 MOZ Rank: 73

  • Axonics was $74 a share on Monday, its highest price since its 2018 initial public offering
  • The medical-device maker is coming off a strong second quarter and an improved yearly financial outlook

Axonics Therapy For OAB

Njurology.com   DA: 13 PA: 17 MOZ Rank: 46

  • Axonics Therapy is an approved treatment for patients suffering with: Overactive bladder (OAB) – the urgent need to urinate which may result in frequent urination and/or incontinence (leakage) episodes
  • Urinary frequency – the need to urinate 8 or more times a …

Recently Analyzed Sites

Revo.com (19 hours ago)

Bobbyjonesband.com (1 day ago)

Huishoubao.com (8 hours ago)

M1file.com (1 day ago)

Trekksoft.com (4 day ago)

Tibbo.com (9 hours ago)

Edgar-online.com (0 seconds ago)

Tailspinbandsc.com (3 day ago)

Dungscanada.com (4 day ago)

Jfsorange.org (1 hours ago)

Marloweslu.com (7 day ago)